Literature DB >> 25327712

Kinetic characterization of the human O-phosphoethanolamine phospho-lyase reveals unconventional features of this specialized pyridoxal phosphate-dependent lyase.

Davide Schiroli1, Luca Ronda, Alessio Peracchi.   

Abstract

Human O-phosphoethanolamine (PEA) phospho-lyase is a pyridoxal 5'-phosphate (PLP) dependent enzyme that catalyzes the degradation of PEA to acetaldehyde, phosphate and ammonia. Physiologically, the enzyme is involved in phospholipid metabolism and is expressed mainly in the brain, where its expression becomes dysregulated in the course of neuropsychiatric diseases. Mechanistically, PEA phospho-lyase shows a remarkable substrate selectivity, strongly discriminating against other amino compounds structurally similar to PEA. Herein, we studied the enzyme under steady-state and pre-steady-state conditions, analyzing its kinetic features and getting insights into the factors that contribute to its specificity. The pH dependence of the catalytic parameters and the pattern of inhibition by the product phosphate and by other anionic compounds suggest that the active site of PEA phospho-lyase is optimized to bind dianionic groups and that this is a prime determinant of the enzyme specificity towards PEA. Single- and multiple-wavelength stopped-flow studies show that upon reaction with PEA the main absorption band of PLP (λmax  = 412 nm) rapidly blue-shifts to ~ 400 nm. Further experiments suggest that the newly formed and rather stable 400-nm species most probably represents a Michaelis (noncovalent) complex of PEA with the enzyme. Accumulation of such an early intermediate during turnover is unusual for PLP-dependent enzymes and appears counterproductive for absolute catalytic performance, but it can contribute to optimize substrate specificity. PEA phospho-lyase may hence represent a case of selectivity-efficiency tradeoff. In turn, the strict specificity of the enzyme seems important to prevent inactivation by other amines, structurally resembling PEA, that occur in the brain.
© 2014 FEBS.

Entities:  

Keywords:  neuropsychiatric diseases; phospholipid metabolism; product inhibition; rapid kinetics; substrate specificity

Mesh:

Substances:

Year:  2014        PMID: 25327712     DOI: 10.1111/febs.13122

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  5 in total

1.  Structural characterization of human O-phosphoethanolamine phospho-lyase.

Authors:  Chiara Vettraino; Alessio Peracchi; Stefano Donini; Emilio Parisini
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-04-01       Impact factor: 1.056

2.  Structural and kinetic characterization of (S)-1-amino-2-propanol kinase from the aminoacetone utilization microcompartment of Mycobacterium smegmatis.

Authors:  Evan Mallette; Matthew S Kimber
Journal:  J Biol Chem       Date:  2018-10-25       Impact factor: 5.157

3.  A Trivalent Enzymatic System for Uricolytic Therapy of HPRT Deficiency and Lesch-Nyhan Disease.

Authors:  Luca Ronda; Marialaura Marchetti; Riccardo Piano; Anastasia Liuzzi; Romina Corsini; Riccardo Percudani; Stefano Bettati
Journal:  Pharm Res       Date:  2017-05-15       Impact factor: 4.200

Review 4.  The Physiological and Pathological Role of Tissue Nonspecific Alkaline Phosphatase beyond Mineralization.

Authors:  Saravanan Sekaran; Selvaraj Vimalraj; Lakshmi Thangavelu
Journal:  Biomolecules       Date:  2021-10-21

5.  Quenching of tryptophan fluorescence in a highly scattering solution: Insights on protein localization in a lung surfactant formulation.

Authors:  Luca Ronda; Barbara Pioselli; Silvia Catinella; Fabrizio Salomone; Marialaura Marchetti; Stefano Bettati
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.